comparemela.com

Yuanbio Venture Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pulnovo Medical Inhales Tens of Millions Dollars Funding to Accelerate Global Growth

/PRNewswire/ Pulnovo Medical Limited, a globally recognized OTM (From Operating Table to Market) innovative platform, today announced the successful close.

Cynthia chenChina national medical products administrationOrbimed healthcare fund managementPrnewswire pulnovo medicalMedical limitedFrom operating tableYuanbio venture capitalCenova capitalLilly asia venturesGaorong capitalHuihe capitalPulmonary artery denervationGlobal trialNational medical products administrationChief strategy officerPulnovo medical

Pulnovo Medical Raises Tens of Millions Dollars Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Orbimed healthcare fund managementNational medical products administrationPulnovo medicalFrom operating tableYuanbio venture capitalCenova capitalLilly asia venturesGaorong capitalHuihe capitalPulmonary artery denervationGlobal trial

China Digest: Worg secures close to $58m; Vathin, HanchorBio raise funds; KKR invests in pet hospital chain

Taiwanese biotech firm HanchorBio has bagged $20m in a Series A funding round

T ai peiSan franciscoUnited statesGambol pet groupNatural pet food groupRuichen pet hospital groupYuexiu industry fundJunson capitalKaitai capitalPet hospital groupNew zealand basedNatural pet foodHong kong listed sino biopharmaceuticalInvestigational new drugPanacea ventureYuanbio venture capital

China Digest: WeTrade files for mixed shelf offering; UnionTech, JoyMed raise funds

UnionTech has notched $29m in a pre-IPO round while JoyMed has bagged over $14m in Series B+

United statesAsia pacificWetrade groupLegend holdingsJoymed technologyTrade groupHong kong basedGoldstone investmentNorth americaCmed technologyHong kong listedLegend capitalYuanbio venture capital

Chinese VC YuanBio Venture raises $219m so far for latest fund

YuanBio, which focuses on early and growth-stage investments, previously raised $150 million for Fund I.

Exchange commissionYuanbio venture capital

vimarsana © 2020. All Rights Reserved.